Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta (Q40491323)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Hendrik Ungefroren

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Stephanie Groth

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Maren Ruhnke

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Holger Kalthoff

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fred Fändrich

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

16 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

280

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2644-2652

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Biglycan knockout mice: new models for musculoskeletal diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Regulation of proteoglycan expression in fibrotic liver and cultured fat-storing cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Transcriptional regulation of the human biglycan gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411925200

21 January 2018

Identifiers

10.1074/JBC.M411925200

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40491323&oldid=1988321733"